erythromycin ethylsuccinate

Generic: erythromycin

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name erythromycin ethylsuccinate
Generic Name erythromycin
Labeler amneal pharmaceuticals ny llc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

erythromycin ethylsuccinate 400 mg/5mL

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 60219-1504
Product ID 60219-1504_0488543c-588b-4b75-acb3-4999aa84ebfc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211204
Listing Expiration 2026-12-31
Marketing Start 2023-12-02

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] macrolide antimicrobial [epc] macrolide [epc] macrolides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 602191504
Hyphenated Format 60219-1504

Supplemental Identifiers

RxCUI
686400 686418
UPC
0360219150317 0360219150423
UNII
1014KSJ86F

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name erythromycin ethylsuccinate (source: ndc)
Generic Name erythromycin (source: ndc)
Application Number ANDA211204 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/5mL
source: ndc
Packaging
  • 100 mL in 1 BOTTLE (60219-1504-2)
source: ndc

Packages (1)

Ingredients (1)

erythromycin ethylsuccinate (400 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0488543c-588b-4b75-acb3-4999aa84ebfc", "openfda": {"upc": ["0360219150317", "0360219150423"], "unii": ["1014KSJ86F"], "rxcui": ["686400", "686418"], "spl_set_id": ["581d7430-1a80-42a6-befb-4c3ae8140392"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BOTTLE (60219-1504-2)", "package_ndc": "60219-1504-2", "marketing_start_date": "20231202"}], "brand_name": "Erythromycin Ethylsuccinate", "product_id": "60219-1504_0488543c-588b-4b75-acb3-4999aa84ebfc", "dosage_form": "SUSPENSION", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "60219-1504", "generic_name": "Erythromycin", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin Ethylsuccinate", "active_ingredients": [{"name": "ERYTHROMYCIN ETHYLSUCCINATE", "strength": "400 mg/5mL"}], "application_number": "ANDA211204", "marketing_category": "ANDA", "marketing_start_date": "20231202", "listing_expiration_date": "20261231"}